Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Postmenopausal Genitourinary Microbiome in Women Undergoing Onabotulinum Toxin Type A for Overactive Bladder - A Feasibility Trial

NCT07025044 is registered in ClinicalTrials.gov with Alexis Dieter as lead sponsor.

NCT NCT07025044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07025044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Postmenopausal Genitourinary Microbiome in Women Undergoing Onabotulinum Toxin Type A for Overactive Bladder - A Feasibility Trial
Lead sponsor
Alexis Dieter
Phase
Observational
Overall status
Recruiting
Start date
September 3, 2025
Completion date
June 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab), urge incontinence